V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011201 | 280005719 | 1.72 | 73 | Palliative (P) | 2018-09-12 | 2018-10-07 | Oxaliplatin + Modified de Gramont | N | N | 280027865 | OXALIPLATIN + MDG |
| 280011202 | 280005723 | 1.69 | 105.8 | Adjuvant (A) | 2014-04-17 | 2014-04-18 | Carboplatin + Paclitaxel (weekly) | 02 | N | 280027880 | CARBOPLATIN + PACLITAXEL |
| 280011203 | 280005727 | 1.54 | 44.6 | Palliative (P) | 2019-06-15 | 2019-06-29 | FLUOROURACIL + IRINOTECAN | null | null | 280027899 | IRINOTECAN + MDG |
| 280011204 | 280005729 | 1.8 | 95.6 | Palliative (P) | 2018-06-25 | 2018-07-12 | Doxorubicin + Ifosfamide | 02 | N | 280027903 | DOXORUBICIN + IFOSFAMIDE |
| 280011205 | 280005732 | 1.82 | null | Curative (C) | 2016-01-19 | 2016-01-22 | Doxorubicin + Olaratumab | N | N | 280027908 | DOXORUBICIN + OLARATUMAB |
| 280011206 | 280009008 | null | 91.55 | Palliative (P) | 2016-10-05 | 2016-10-10 | Etoposide + Ifosfamide (3 days) | 02 | N | 280027914 | ETOPOSIDE + IFOSFAMIDE |
| 280011207 | 280005738 | 1.63 | 60.1 | Curative (C) | 2012-12-08 | 2013-03-28 | VAI (Ifos 3g/m2) | null | null | 280027926 | VAI |
| 280011208 | 280009014 | 1.84 | null | Palliative (P) | 2014-08-12 | 2014-08-17 | Cyclophosphamide Weekly PO | null | null | 280027969 | CYCLOPHOSPHAMIDE |
| 280011209 | 280005747 | 1.82 | 43.7 | Curative (C) | 2012-06-23 | 2013-09-14 | VAC | 02 | N | 280027971 | CAV |
| 280011210 | 280005755 | 1.5 | 72.4 | Curative (C) | null | 2015-05-05 | Cisplatin+Gemcitabine (gallbladder) | N | Y | 280027992 | CISPLATIN + GEMCITABINE |
| 280011211 | 280009017 | 1.71 | 85.2 | Palliative (P) | 2017-10-03 | 2017-11-04 | Doxorubicin + Ifosfamide | Y | N | 280027992 | DOXORUBICIN + IFOSFAMIDE |
| 280011212 | 280009018 | 1.77 | 64.8 | Curative (C) | 2019-02-06 | 2019-02-28 | Carboplatin + Etoposide iv&po | N | N | 280028006 | CARBOPLATIN + ETOPOSIDE |
| 280011213 | 280005763 | 1.7 | null | Palliative (P) | null | 2017-10-09 | Gemcitabine day 1&8 | null | null | 280028009 | GEMCITABINE |
| 280011214 | 280009020 | 1.6 | 64.8 | Neo-adjuvant (N) | 2015-04-20 | 2015-05-05 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028015 | EURO-EWING |
| 280011215 | 280005767 | 0 | 63 | Curative (C) | 2018-05-08 | 2018-05-12 | Carboplatin + Etoposide IV 3 day | 02 | N | 280028023 | CARBOPLATIN + ETOPOSIDE |
| 280011216 | 280005781 | 1.86 | 70 | Palliative (P) | 2013-06-24 | 2013-12-05 | Doxorubicin + Ifosfamide | N | N | 280028075 | DOXORUBICIN + IFOSFAMIDE |
| 280011217 | 280005786 | 1.71 | null | Palliative (P) | 2013-11-24 | 2013-11-28 | CAV | 2 | N | 280028086 | CAV |
| 280011218 | 280009030 | 1.8 | null | null | 2017-03-19 | 2017-04-27 | CISPLATIN + FLUOROURACIL | N | N | 280028090 | CISPLATIN + FLUOROURACIL |
| 280011219 | 280009032 | 1.66 | 74.7 | Palliative (P) | 2017-07-29 | 2017-07-30 | DE-ESCALATE TRIAL | Y | N | 280028098 | DE-ESCALATE TRIAL |
| 280011220 | 280005794 | 1.74 | 62 | Palliative (P) | 2016-07-06 | 2016-07-09 | Cyclophosphamide oral | 1 | N | 280028114 | CYCLOPHOSPHAMIDE |
| 280011221 | 280009035 | 1.86 | 77 | Palliative (P) | 2015-11-29 | 2015-11-29 | Carboplatin + Etoposide IV 3 day | N | N | 280028123 | CARBOPLATIN + ETOPOSIDE |
| 280011222 | 280005800 | 1.61 | 75 | Palliative (P) | 2014-01-24 | 2014-01-24 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280028141 | CARBOPLATIN + PACLITAXEL |
| 280011223 | 280005803 | 0 | 73.8 | Palliative (P) | 2015-07-06 | 2015-07-13 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028146 | CETUXIMAB + CISPLATIN + FU |
| 280011224 | 280005808 | 1.78 | 35.9 | Palliative (P) | 2017-08-31 | 2018-01-13 | Oxaliplatin + Modified de Gramont | 02 | N | 280028151 | OXALIPLATIN + MDG |
| 280011225 | 280005809 | 1.73 | 0 | Neo-adjuvant (N) | 2016-07-17 | 2016-08-01 | ETOPOSIDE + IFOSFAMIDE | N | N | 280028152 | ETOPOSIDE + IFOSFAMIDE |
| 280011226 | 280005812 | 1.67 | 0 | Curative (C) | 2018-06-23 | 2018-07-06 | FLUOROURACIL + OXALIPLATIN | N | N | 280028180 | OXALIPLATIN + MDG |
| 280011227 | 280005815 | 1.86 | 61.7 | Radical (R) | 2018-08-14 | 2018-08-18 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028182 | CETUXIMAB + CISPLATIN + FU |
| 280011228 | 280010600 | 1.71 | null | Palliative (P) | null | 2015-03-08 | CARBOPLATIN + ETOPOSIDE | N | N | 280028183 | CARBOPLATIN + ETOPOSIDE |
| 280011229 | 280005822 | 1.62 | 70 | Palliative (P) | 2018-06-08 | 2018-08-01 | CARBOPLATIN + ETOPOSIDE | null | null | 280028184 | CARBOPLATIN + ETOPOSIDE |
| 280011230 | 280005826 | 1.66 | 58.3 | Palliative (P) | null | 2017-01-27 | Irinotecan + Temozolomide | 02 | N | 280028205 | VAI |
| 280011231 | 280005826 | 1.72 | 73.5 | Curative (C) | 2015-07-16 | 2015-08-10 | Doxorubicin + Ifosfamide | 2 | N | 280028205 | DOXORUBICIN + IFOSFAMIDE |
| 280011232 | 280005829 | 1.71 | null | Palliative (P) | 2018-11-17 | 2018-11-17 | Irinotecan + Temozolomide | null | null | 280028214 | VAI |
| 280011233 | 280010602 | 1.66 | 70 | Palliative (P) | 2017-06-15 | 2018-05-16 | Cisplatin +Fluorouracil (2 wk) | N | N | 280028217 | CISPLATIN + FLUOROURACIL |
| 280011234 | 280005833 | 1.59 | 113.5 | Adjuvant (A) | 2017-12-15 | 2017-12-29 | Cisplatin +Fluorouracil (2 wk) | 02 | N | 280028233 | CISPLATIN + FLUOROURACIL |
| 280011235 | 280005833 | null | 61.7 | Curative (C) | 2018-11-13 | 2018-11-13 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 280028233 | CISPLATIN + GEMCITABINE |
| 280011236 | 280009058 | null | 52 | Palliative (P) | 2014-05-30 | 2014-06-13 | DE-ESCALATE TRIAL | null | null | 280028240 | DE-ESCALATE TRIAL |
| 280011237 | 280009061 | 1.75 | 98.4 | Palliative (P) | 2012-12-01 | 2013-12-24 | Carboplatin + Etoposide IV 3 day | 2 | N | 280028255 | CARBOPLATIN + ETOPOSIDE |
| 280011238 | 280005841 | 1.66 | 103.05 | Palliative (P) | 2014-02-18 | 2014-02-26 | Oxaliplatin + Modified de Gramont | null | null | 280028259 | OXALIPLATIN + MDG |
| 280011239 | 280005848 | 1.7 | 46 | Palliative (P) | 2016-05-12 | 2016-11-07 | Oxaliplatin + Modified de Gramont | 2 | N | 280028275 | OXALIPLATIN + MDG |
| 280011240 | 280005852 | 1.7 | null | Neo-adjuvant (N) | 2017-04-16 | 2017-04-24 | CISPLATIN + GEMCITABINE | N | N | 280028277 | CISPLATIN + GEMCITABINE |
| 280011241 | 280010608 | 1.74 | 75.9 | Palliative (P) | 2016-01-08 | 2016-01-08 | Doxorubicin + Ifosfamide | 02 | N | 280028292 | DOXORUBICIN + IFOSFAMIDE |
| 280011242 | 280009071 | 1.57 | 107.4 | Palliative (P) | 2014-05-31 | 2014-07-06 | CARBOPLATIN + ETOPOSIDE | N | N | 280028300 | CARBOPLATIN + ETOPOSIDE |
| 280011243 | 280005859 | 1.62 | 71.4 | Neo-adjuvant (N) | 2014-02-17 | 2014-02-17 | CISPLATIN + FLUOROURACIL | null | null | 280028302 | CISPLATIN + FLUOROURACIL |
| 280011244 | 280009075 | 1.65 | 100 | Curative (C) | 2018-06-05 | 2018-06-11 | CISPLATIN + FLUOROURACIL | N | N | 280028320 | CISPLATIN + FLUOROURACIL |
| 280011245 | 280005868 | 1.57 | null | Palliative (P) | 2014-10-09 | 2014-10-17 | CARBOPLATIN + ETOPOSIDE | N | null | 280028322 | CARBOPLATIN + ETOPOSIDE |
| 280011246 | 280005873 | 1.61 | 93.7 | Palliative (P) | 2016-09-26 | 2016-11-13 | DE-ESCALATE TRIAL | 02 | null | 280028330 | DE-ESCALATE TRIAL |
| 280011247 | 280005874 | 1.59 | 81.4 | Palliative (P) | 2016-10-05 | 2016-10-21 | Doxorubicin + Olaratumab | 2 | N | 280028334 | DOXORUBICIN + OLARATUMAB |
| 280011248 | 280010617 | 1.59 | 54 | Curative (C) | 2017-01-08 | 2017-01-28 | Doxorubicin + Ifosfamide | N | N | 280028345 | DOXORUBICIN + IFOSFAMIDE |
| 280011249 | 280005880 | 0 | 75.6 | Palliative (P) | 2017-05-18 | 2017-10-13 | Doxorubicin + Olaratumab | N | N | 280028353 | DOXORUBICIN + OLARATUMAB |
| 280011250 | 280010619 | 1.53 | null | Palliative (P) | 2018-07-17 | 2018-07-17 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 280028363 | GEMCITABINE |